1
Evan C Unger, Dekang Shen, Guanli Wu: Cationic lipids and the use thereof. ImaRx Pharmaceutical, Woodcock Washburn Kurtz Mackiewicz & Norris, November 3, 1998: US05830430 (105 worldwide citation)

Cationic lipid compounds which comprise at least two cationic groups. The cationic lipid compounds are particularly suitable for use as carriers in the intracellular delivery of bioactive agents, including pharmaceuticals and genetic material. Compositions of the present cationic lipid compounds inc ...


2
Evan C Unger, Dekang Shen, Guanli Wu: Cationic lipids and the use thereof. Imarx Pharaceutical, Woodcock Washburn Kurtz Mackiewicz & Norris, May 2, 2000: US06056938 (46 worldwide citation)

Cationic lipid compounds which comprise at least two cationic groups. The cationic lipid compounds are particularly suitable for use as carriers in the intracellular delivery of bioactive agents, including pharmaceuticals and genetic material. Compositions of the present cationic lipid compounds inc ...


3
Evan C Unger, DeKang Shen: Liposoluble compounds useful as magnetic resonance imaging agents. Woodcock Washburn Kurtz Mackiewicz & Norris, May 17, 1994: US05312617 (43 worldwide citation)

Novel complexes of paramagnetic ions and compounds bearing long acyl chains have been synthesized as magnetic resonance imaging contrast agents. These novel liposoluble contrast agents may be administered alone, or with lipids, suspending agents or other additives. The lipids may be in the form of l ...


4
Evan C Unger, DeKang Shen: Lipid soluble steroid prodrugs. Imarx Pharmaceutical, Woodcock Washburn Kurtz Mackiewicz & Norris, July 18, 2000: US06090800 (38 worldwide citation)

The present invention is directed to novel lipid soluble steroid prodrugs compositions comprising steroid prodrugs, and uses of the same.


5
Evan C Unger, Dekang Shen, Guanli Wu: Silicon amphiphilic compounds and the use thereof. Imarx Therapeutics, Woodcock Washburn, July 2, 2002: US06414139 (27 worldwide citation)

Novel silicon amphiphilic compounds which comprise a silicon residue. The silicon amphiphilic compounds are particularly suitable for use in compositions for diagnostic imaging, such as ultrasound. Compositions of the silicon amphiphilic compounds comprise a gas or gaseous precursor, and may take th ...


6
Evan C Unger, DeKang Shen: Lipid soluble steroid prodrugs. Imarx Therapeutics, Woodcock Washburn, September 3, 2002: US06444660 (15 worldwide citation)

The present invention is directed to novel lipid soluble steroid prodrugs, compositions comprising steroid prodrugs, and uses of the same.


7
Evan C Unger, DeKang Shen: Liposoluble compounds useful as magnetic resonance imaging agents. ImaR sub x Pharmaceutical, Woodcock Washburn Kurtz Mackiewicz & Norris, November 14, 1995: US05466438 (10 worldwide citation)

Novel complexes of paramagnetic ions and compounds bearing long acyl chains have been synthesized as magnetic resonance imaging contrast agents. These novel liposoluble contrast agents may be administered alone, or with lipids, suspending agents or other additives. The lipids may be in the form of l ...


8
Evan C Unger, DeKang Shen: Liposoluble compounds useful as magnetic resonance imaging agents. ImaRx Pharmaceuticals, Woodcock Washburn Kurtz Mackiewicz & Norris, January 4, 2000: US06010682 (9 worldwide citation)

Novel complexes of paramagnetic ions and compounds bearing long acyl chains have been synthesized as magnetic resonance imaging contrast agents. These novel liposoluble contrast agents may be administered alone, or with lipids, suspending agents or other additives. The lipids may be in the form of l ...


9
Evan C Unger, DeKang Shen: Liposoluble compounds useful as magnetic resonance imaging agents. ImaRx Pharmaceutical, Woodcock Washburn Kurtz Mackiewicz & Norris, June 9, 1998: US05762910 (8 worldwide citation)

Novel complexes of paramagnetic ions and compounds bearing long acyl chains have been synthesized as magnetic resonance imaging contrast agents. These novel liposoluble contrast agents may be administered alone, or with lipids, suspending agents or other additives. The lipids may be in the form of l ...


10
Evan C Unger, DeKang Shen: Liposoluble heterocyclic compounds useful as magnetic resonance imaging agents. ImaRx Pharmaceutical Corporation, Woodcock Washburn Kurtz Mackiewicz & Norris, April 29, 1997: US05624662 (3 worldwide citation)

Novel complexes of paramagnetic ions and compounds bearing long acyl chains have been synthesized as magnetic resonance imaging contrast agents. These novel liposoluble contrast agents may be administered alone, or with lipids, suspending agents or other additives. The lipids may be in the form of l ...